Highlights
NASDAQ: BTAI       Bioxcel Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
6.31   +0.39 (6.59%)  5.92 - 6.38  69,121

Overview

 
Avg Volume (4 weeks):185,052
4 Weeks Range:4.20 - 7.35
4 Weeks Price Volatility (%):
66.98%
52 Weeks Range:2.41 - 12.00
52 Weeks Price Volatility (%):
40.67%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, which is a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company's other product candidates are BXCL502 and BXCL702 which is focused on neurodegeneration and hematological malignancies.

  Be the first to like this.
 


 

3640  2100  313  2918 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 CHK 0.783+0.037 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers